Insight Molecular Diagnostics (IMDX) Common Equity (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Common Equity of -$21.3 million for Q2 2026, compared with $1.1 million a year earlier.
Powered by 
Analysis
Insight Molecular Diagnostics (IMDX) Common Equity (2015 - 2026) Analysis & Trends
At the end of FY2025, Insight Molecular Diagnostics' Common Equity came in at -$31.46 million.
- In prior years, Insight Molecular Diagnostics' Common Equity was -$12.27 million in FY2024, $20.47 million in FY2023 (-40.3%), $34.29 million in FY2022 (-47.4%) and $65.22 million in FY2021 (+94.8%).
- Quarterly Common Equity has run from a low of -$31.46 million in Q4 2025 to a high of $99.35 million in Q3 2021 over five years.
- The strongest year-over-year quarter for Common Equity in the past five years was Q3 2021, with growth of 186.8%; the weakest was Q2 2025, with a decline of 95.2%.
- According to Business Quant data, Common Equity for the three prior quarters was -$10.69 million (Q1 2026), -$31.46 million (Q4 2025) and -$9.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Insight Molecular Diagnostics | 103.74 Mn | 27.46 Mn | 157,000.00 | -21.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.30 Mn |
| Mar 31, 2026 | -10.69 Mn |
| Dec 31, 2025 | -31.46 Mn |
| Sep 30, 2025 | -9.20 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 10.22 Mn |
| Dec 31, 2024 | -12.27 Mn |
| Sep 30, 2024 | 9.71 Mn |
| Jun 30, 2024 | 22.70 Mn |
| Mar 31, 2024 | 11.59 Mn |
| Dec 31, 2023 | 20.47 Mn |
| Sep 30, 2023 | 36.14 Mn |
| Jun 30, 2023 | 43.60 Mn |
| Mar 31, 2023 | 37.93 Mn |
| Dec 31, 2022 | 34.29 Mn |
| Sep 30, 2022 | 76.86 Mn |
| Jun 30, 2022 | 83.24 Mn |
| Mar 31, 2022 | 56.97 Mn |
| Dec 31, 2021 | 65.22 Mn |
| Sep 30, 2021 | 99.35 Mn |
API Access
Insight Molecular Diagnostics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();